PL350520A1 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
PL350520A1
PL350520A1 PL00350520A PL35052000A PL350520A1 PL 350520 A1 PL350520 A1 PL 350520A1 PL 00350520 A PL00350520 A PL 00350520A PL 35052000 A PL35052000 A PL 35052000A PL 350520 A1 PL350520 A1 PL 350520A1
Authority
PL
Poland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
PL00350520A
Inventor
Bernt Borretzen
Vidar Moen
Rolf Olaf Larsen
Erik Olai Pettersen
Geir Sagvolden
Camilla Bruno Dunsaed
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of PL350520A1 publication Critical patent/PL350520A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL00350520A 1999-02-19 2000-02-18 Chemical compounds PL350520A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives
PCT/NO2000/000060 WO2000048610A1 (en) 1999-02-19 2000-02-18 Chemical compounds

Publications (1)

Publication Number Publication Date
PL350520A1 true PL350520A1 (en) 2002-12-16

Family

ID=19902986

Family Applications (2)

Application Number Title Priority Date Filing Date
PL00350519A PL350519A1 (en) 1999-02-19 2000-02-18 Chemical compounds
PL00350520A PL350520A1 (en) 1999-02-19 2000-02-18 Chemical compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL00350519A PL350519A1 (en) 1999-02-19 2000-02-18 Chemical compounds

Country Status (15)

Country Link
EP (2) EP1150690A1 (en)
JP (2) JP2002537263A (en)
CN (2) CN1347323A (en)
AU (2) AU2834200A (en)
BR (2) BR0008302A (en)
CA (2) CA2362306A1 (en)
CZ (2) CZ20012965A3 (en)
HU (2) HUP0105281A2 (en)
IL (2) IL144895A0 (en)
MX (2) MXPA01008346A (en)
NO (1) NO309305B1 (en)
PL (2) PL350519A1 (en)
RU (2) RU2001123035A (en)
SK (2) SK11602001A3 (en)
WO (2) WO2000048609A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096921A1 (en) * 2001-05-30 2002-12-05 Nisshin Seifun Group Inc. Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine
DE10261807A1 (en) 2002-12-19 2004-07-01 Turicum Drug Development Ag Deuterated catecholamine derivatives and medicinal products containing these compounds
CN102134232B (en) * 2005-07-26 2012-11-21 奈科明有限责任公司 Isotopically substituted proton pump inhibitor
AR054583A1 (en) * 2005-07-26 2007-06-27 Altana Pharma Ag PANTOPRAZOL ISOTOPICALLY REPLACED
WO2007041630A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
CN101157711B (en) * 2007-09-28 2010-12-08 西安交通大学 Compound having antineoplastic activity and uses thereof
MX339451B (en) * 2008-04-03 2016-05-27 Cognate 3 Llc Compositions and methods for immunotherapy.
CN101735284B (en) * 2008-11-24 2012-05-23 上海医药工业研究院 Method for preparing 4, 6-O-benzylidene-D-glucopyranose
CN114366741A (en) 2013-12-03 2022-04-19 细胞内治疗公司 New method
US10077267B2 (en) 2014-04-04 2018-09-18 Intra-Cellular Therapies, Inc. Organic compounds
JP6898072B2 (en) * 2015-08-27 2021-07-07 秀行 佐谷 14-3-3 Protein activity regulator
ES2879888T3 (en) 2016-03-25 2021-11-23 Intra Cellular Therapies Inc Organic compounds and their use in the treatment or prevention of disorders of the central nervous system
JP7013454B2 (en) 2016-10-12 2022-02-15 イントラ－セルラー・セラピーズ・インコーポレイテッド Amorphous solid dispersion
BR112019019875A2 (en) 2017-03-24 2020-04-22 Intra Cellular Therapies Inc new compositions and methods
BR112021003655A2 (en) 2018-08-31 2021-05-18 Intra-Cellular Therapies, Inc. new methods
US10695345B2 (en) 2018-08-31 2020-06-30 Intra-Cellular Therapies, Inc. Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB811510A (en) * 1954-12-20 1959-04-08 Gyogyszeripari Ki New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof
JPS6112623A (en) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd Encephalinase inhibiting agent
JPS6256423A (en) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd Remedy and ameliorating agent for cachexia
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
JPH07145191A (en) * 1993-11-24 1995-06-06 Japan Tobacco Inc Galactosyl phosphonate derivative

Also Published As

Publication number Publication date
HUP0105280A2 (en) 2002-04-29
JP2002537263A (en) 2002-11-05
NO990814D0 (en) 1999-02-19
NO309305B1 (en) 2001-01-15
IL144895A0 (en) 2002-06-30
MXPA01008346A (en) 2003-06-06
RU2001123124A (en) 2004-02-20
CA2363670A1 (en) 2000-08-24
CN1347323A (en) 2002-05-01
MXPA01008347A (en) 2004-03-10
PL350519A1 (en) 2002-12-16
IL144896A0 (en) 2002-06-30
WO2000048610A1 (en) 2000-08-24
CN1347322A (en) 2002-05-01
CA2362306A1 (en) 2000-08-24
AU2834200A (en) 2000-09-04
WO2000048609A1 (en) 2000-08-24
HUP0105281A2 (en) 2002-05-29
AU2834100A (en) 2000-09-04
RU2001123035A (en) 2004-03-20
NO990814L (en) 2000-08-21
CZ20012965A3 (en) 2002-03-13
JP2002537264A (en) 2002-11-05
BR0008302A (en) 2002-08-27
SK11612001A3 (en) 2002-04-04
CZ20012966A3 (en) 2002-03-13
SK11602001A3 (en) 2002-02-05
EP1150690A1 (en) 2001-11-07
BR0008297A (en) 2002-05-28
EP1150689A1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
PL350519A1 (en) Chemical compounds
GB9903861D0 (en) Chemical compounds
GB9910104D0 (en) Chemical compounds
GB9910110D0 (en) Chemical compounds
GB9914025D0 (en) Chemical compounds
GB9900078D0 (en) Chemical compounds
GB9910394D0 (en) Chemical compounds
GB9914015D0 (en) Chemical compounds
GB9914024D0 (en) Chemical compounds
GB9908355D0 (en) Chemical compounds
GB9910419D0 (en) Chemical compounds
GB9914022D0 (en) Chemical compounds
GB9903860D0 (en) Chemical compounds
GB9910647D0 (en) Chemical compounds
GB9905462D0 (en) Chemical compounds
GB9905463D0 (en) Chemical compounds
GB9905076D0 (en) Chemical compounds
GB9904506D0 (en) Chemical compounds
GB9906564D0 (en) Chemical compounds
GB9906565D0 (en) Chemical compounds
GB9905078D0 (en) Chemical compounds
GB9903859D0 (en) Chemical compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)